|
|
 |
|
Viewing report
|
|
|
|
Amylin Pharmaceuticals, Inc.
Wright Investors' Service, May 2009, Pages: 51
Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio tables (Accounting, Asset Utilization, Employee Efficiency, Fixed Charges Coverage, Leverage Analysis, Liquidity Analysis, Per-share Data and Profitability Analysis) and proprietary Wright Quality Rating analyses tables. The Wright Quality Rating, a measure of corporate risk, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of Amylin Pharmaceuticals, Inc.. There is a textual review of the financial results of Amylin Pharmaceuticals, Inc. versus Elan Corporation PLC, Warner Chilcott Limited and Valeant Pharmaceuticals International. The comparative analysis of these companies compares Sales (sales, sales growth and sales per employee), Company Valuations (Price/Earnings, Price/Book, Price/Sales and 52-Week Price Change) and Financial Position (Long-term Debt/Equity). Also included for Amylin Pharmaceuticals, Inc. are the Company Description, Recent Stock Performance, Profitability Analysis, Dividend Analysis, and Key Data Items (Ticker, Major Industry, Sub-Industry, Fiscal Year End Month, Employees, Share Type, Market Capitalization, Total Shares Outstanding and Number of Closely Held Shares.) Additional research for Amylin Pharmaceuticals, Inc.includes tables with up to 10-years of history of computed ratios, sales, earnings, and security prices.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Premium Company Profile - Amylin Pharmaceuticals
Amylin Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
Amylin Pharmaceuticals, Inc. - SWOT Analysis
Amylin Pharmaceuticals, Inc.
Analysis of Amylin Pharmaceuticals
Inspire Pharmaceuticals, Inc.
King Pharmaceuticals, Inc.
Novabay Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc.
Alseres Pharmaceuticals Inc
Anadys Pharmaceuticals, Inc.
Cortex Pharmaceuticals, Inc.
|
|
|
|
